Low-dose, once-daily atazanavir/ritonavir (200/100): An effective treatment for HIV-infected patients in Thailand

Journal of Acquired Immune Deficiency Syndromes

Volumn 49, Issue 2, 2008, Pages 230-231

  Chetchotisakd, Ploenchan ^a   Anunnatsiri, Siriluck ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ATAZANAVIR PLUS RITONAVIR; CHOLESTEROL; DIDANOSINE; EFAVIRENZ; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LAMIVUDINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; TRIACYLGLYCEROL; VIRUS RNA; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ATAZANAVIR; OLIGOPEPTIDE; PYRIDINE DERIVATIVE; RITONAVIR;

ADULT; CD4 LYMPHOCYTE COUNT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THAILAND; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS LOAD; AGED; DRUG COMBINATION; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AGED; ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OLIGOPEPTIDES; PYRIDINES; RITONAVIR; THAILAND; TREATMENT OUTCOME;

EID: 55249090146     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31817cfdc9     Document Type: Letter

References (4)

1. Agarwala S, Russo R, Mummaneni V, et al. Steady-state pharmacokinetic (PK) interaction study of atazanavir (ATV) with ritonavir (RTV) in healthy subjects. In: Abstract of the FortySecond Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. Abstract H-1716. Washington, DC: American Society for Microbiology; 2002:274.
2. 3:96-week outcomes. Antivir Ther. 2005;10: 911-916.
3. AIDSinfo. Guideline for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents. Available at: http://AIDSuifo.iiih. gov. Accessed February 23, 2008. Rockville, MD: U.S. Department of Health, and Human Services; 2007.
4. Poirier JM, Guiard-Schmid JB, Meynard JL, et al. Critical drug interaction between ritonavirboosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors. AIDS. 2006;20: 1087-1089.